Evidence map›Paper›PMID 31284438›Full record

ArticleAntioxidants (Basel, Switzerland)2019

Sesamol Inhibited Ultraviolet Radiation-Induced Hyperpigmentation and Damage in C57BL/6 Mouse Skin.

Ya-Jhen You, Po-Yuan Wu, Yi-Jung Liu, Chien-Wei Hou, Chin-Sheng Wu, Kuo-Ching Wen, Chien-Yih Lin, Hsiu-Mei Chiang

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antioxidants and Skin Protection.Antioxidants (Basel, Switzerland) · 2020
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ya-Jhen YouDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan.
Po-Yuan WuDepartment of Dermatology, China Medical University Hospital, Taichung 40402, Taiwan.
Yi-Jung LiuDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan.
Chien-Wei HouDepartment of Biotechnology and Pharmaceutical Technology, Yuanpei University of Medical Technology, Hsinchu 30015, Taiwan.
Chin-Sheng WuDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan.
Kuo-Ching WenDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan.
Chien-Yih LinDepartment of Biotechnology, Asia University, Taichung 41354, Taiwan. yihlin@asia.edu.tw.
Hsiu-Mei ChiangDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan. hmchiang@mail.cmu.edu.tw.ORCID 0000-0002-1586-910X
China Medical University · TWAsia University · TWYuanpei University · TW

Funding

China Medical University CMU105-ASIA-08, CMU106-ASIA-20Ministry of Science and Technology MOST104-2320-B-039-006Top University Plan of the Ministry of Education, Taiwan, and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence MOHW104-TDU-B-212-113002
6 · The paper itself

Abstract

Melanin is synthesized through a series of oxidative reactions initiated with tyrosine and catalyzed by melanogenesis-related proteins such as tyrosinase, tyrosinase-related protein-1 (TRP-1), dopachrome tautomerase (TRP-2), and microphthalmia-associated transcription factor (MITF). Our previous study demonstrated that sesamol inhibited melanin synthesis through the inhibition of the melanocortin 1 receptor (MC1R)/MITF/tyrosinase pathway in B16F10 cells. In this study, sesamol was applied to C57BL/6 mouse skin to understand its activity with respect to skin pigmentation. The results indicated that ultraviolet (UV) B-induced hyperpigmentation in the C57BL/6 mouse skin was significantly reduced by topical application of sesamol for 4 weeks. Sesamol reduced the melanin index and melanin content of the skin. In addition, sesamol elevated the brightness (L* value) of the skin. Sesamol also reduced UVB-induced hyperplasia of epidermis and collagen degradation in dermis. In immunohistochemical staining, topical application of sesamol reduced UVB-induced tyrosinase, TRP-1, TRP-2, and MITF expression in the epidermis of the skin. These results demonstrated that sesamol is a potent depigmenting agent in the animal model.

Indexed as

melanogenesismicrophthalmia-associated transcription factorsesamoltyrosinasetyrosinase-related protein-1

Identifiers

PMID31284438
PMCPMC6680965
OpenAlexW2954191578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.